A Study Exploring Olaparib and Temozolomide in Small Cell Lung Cancer

3 Views
administrator
administrator
07/14/23

Anna Farago, MD, PhD, assistant, medicine, Massachusetts General Hospital, discusses a phase I study of olaparib (Lynparza) and temozolomide (Temodar) in patients with small cell lung cancer who had progression after 1 prior line of platinum-based chemotherapy.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next